Medical management of cholangiocarcinoma;Prise en charge médicale des cholongiocarcinomes

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 1, 2004, Pages 57-65

  Barrioz, Thierry ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

BILE DUCT CARCINOMA; BILE DUCT PROSTHESIS; BILIARY TRACT DRAINAGE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMMON BILE DUCT OBSTRUCTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; EVALUATION; FOLLOW UP; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; QUALITY OF LIFE; REVIEW; STENT; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 1542621075     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)94842-7     Document Type: Review

References (65)

1. Renard P, Faivre J, Boutron MC, Milan C, Bedenne L, Klepping C. Le cancer de la vésicule biliaire dans le département de la Côte-d'Or. Gastroenterol Clin Biol 1987; 11:237-41.
2. Schaffer P, Lavillaureix J. Le cancer dans le Bas-Rhin. Incidence des nouveaux cas de 1975 à 1977. Paris: Economica, 1981.
3. Ritchie JK, Allan RN, Mc.Cartney J, Thompson H, Hawley PR, Cooke WT. Biliary tract carcinoma associated with ulcerative colitis. Q J Med 1974;43:263-79.
4. Todani T, Tabuchi K, Watanabe Y, Kobayashi T. Carcinoma arising in the wall of congenital bile duct cysts. Cancer 1979;44:1134-41.
5. Nagorney DM, McIIrath DC, Adson MA. Choledochal cysts in adults: clinical management. Surgery 1984;96:656-63.
6. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975;140: 170-8.
7. Bhuiya MR, Nimura Y, Kamiya J, Kondo S, Fukata S, Hayakawa N, et al. Clinico-pathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 1992;215:344-9.
8. Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet 1986; 162:153-8.
9. Bret PM, Reinhold C, Taourel P, Guibaud L, Atri M, Barkun AN. Pancreasdivisum: evaluation with MR cholangiopancreatography. Radiology 1996;199:99-103.
10. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP): a study of 10 000 cases. Gastroenterology 1976;70:314-20.
11. Harbin WP, Mueller P, Ferruci JT. Transhepaticcholangiography: complications and use pattern of the fine-needle technique. Radiology 1980;135:15-22.
12. Assouline Y, Liguory C, Ink O, Fritsch J, Choury AD, Lefebvre JF, et al. Résultats actuels de la sphinctérotomie endoscopique pour lithiase de la voie biliaire principale. Gastroenterol Clin Biol 1993; 17:251-8.
13. Reinhold C, Bret PM. Current status of MRcholangio-pancreatography. Am J Roentgenol 1996; 166:1285-95.
14. Morimoto K, Shimoi M, Shirakawa T, Aoki Y, Choi S, Miyata Y, et al. Biliary obstruction: evaluation with three dimensional MR cholangiography. Radiology 1992;183:578-80.
15. Soto JA, Barish MA, Yucel EK, Ferrucci JT. MRcholangiopancreatography : findings on 3D fast spin-echo imaging. Am J Roentgenol 1995; 165:1397-401.
16. Barish MA, Yucel EK, Soto JA, Chuttani R, Ferrucci JT. MR cholangiopancreatography : efficacy of three-dimensional turbo spin-echo technique. Am J Roentgenol 1995; 165:295-300.
17. Miyazaki T, Yamashita T, Tsuchigame T, Yamamoto H, Urata J, Takahashi M. MR cholangiopancreatography using HASTE (half-Fourier acquisition single-shotturbo spin-echo) sequences. Am J Roentgenol 1996;166:1297-303.
18. Ernst O, Calvo M, Sergent G, Mizrahi D, Carpentier F. Breath-hold MR cholangiopancreatography using a HASTE sequence: comparison of single sliceand multislice acquisition techniques. Am J Roentgenol 1997;169:1304-6.
19. Hall-Crags MA, Allen CM, Owens CM, Wilkinson AD, Chong WR, Lees WR, et al. MR cholangiography: clinical evaluation in 40 cases. Radiology 1993; 189:423-7.
20. Low RN, Sigeti JS, Francis IR, Weinman D, Bower B, Shimakawa A, et al. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiledgradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography. Am J Roentgenol 1994;162:315-23.
21. Amouyal P, Palazzo L, Amouyal G, Ponsot P, Monpint D, Vilgrain V, et al. Endosonography: promising method for diagnosis of extrahepatic cholestasis. Lancet 1989;ii: 1195-8.
22. Dancygier GH, Natermann C. The rote of endoscopic ultrasonography in biliary tract diseases: obstructive jaundice. Endoscopy 1994;26: 800-2.
23. Jellouli F, Keriven-Souquez O, Henry L, Napoléon-B, Pujol B, Valette PJ, et al. Endoscopic ultrasound and Spiral CT scan for biliopancreatic cancer: preliminary prospective study of 40 patients. Endoscopy 1996;28, N°8: S5.
24. Bret PM, Reinhold C. Magnetic Resonance Cholangiopancreatography. Endoscopy 1997;29:472-6.
25. Cannon ME, Carpenter SL, Elta GH, Nostrant TT, Kochman ML, Ginsberg GG, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 1999; 50:27-33.
26. Tio TL, Cheng J, Wijers OB, Sars PRA, Tytgat GNJ. Endosonographic TNM staging of extrahepatic bile duct cancer: comparison with pathological staging. Gastroenterology 1991;100:1351-61.
27. Fujita N, Noda Y, Kobayashi G, Kimura K, Yago A. Staging of bile duct carcinoma by EUS and IDUS. Endoscopy 1998;30 (Suppl 1): A132-A134.
28. Tamada K, Ido K, Ueno N, Kimura K, Ichiyama M, Tomiyama T. Preoperative staging of extrahepatic bile duct cancer with intraductal ultrasonography. Am J Gastroenterol 1995;90:239-46.
29. Inui K. Nakazawa S. Yoshino J. Wakabayashi T, Okushima K, Nakamura Y, et al. Ultrasound probes for biliary lesions. Endoscopy 1998;30 (Suppl 1): A 120-123.
30. Prat F, Chapat O, Ducot B, Ponchon T, Fritsch J, Choury AD, et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 1998 Jan;42(1): 76-80.
31. Dumas R, Demarquay JF, Caroli-Bosc FX, Paolini O, Guenenna D, Peten EP, et al. Gastroenterol Clin Biol 2000;24:714-8.
32. Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114:536-42.
33. Adam A. Metallic biliary endoprostheses. Cardiovasc Intervent Radiol 1994;17:127-32.
34. Lammer J. Biliary endoprostheses. Plastic versus metal stents. Radiol Clin North Am 1990;28:1211-22.
35. Stoker J, Lameris JS. Complications of percutaneously inserted biliary Wallstents. J Vasc Intervent Radiol 1993;4:767-72.
36. Lammer J, Hausegger KA, Flückiger F, Winkelbauer FW, Wildling R, Klein GE, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 1996;201:167-72.
37. Lee MJ, Dawson SL, Mueller PR, Hahn PF, Saini S, Lu DSK, et al. Failed metallic biliary stents: causes and management of delayed complications. Clin Radiol 1994;49:857-62.
38. Rossi P, Bezzi M, Rossi M, Adam A, Chetty N, Roddie ME, et al. Metallic stents in malignant biliary obstruction: results of a multicenter european study of 240 patients. J Vasc Intervent Radiol 1994;5:279-85.
39. Becker CD, Glättli A, Maibach R, Baer HU. Percutaneous palliation of malignant obstructive jaundice with the wallstent endoprothesis: follow-up and reintervention in patients with hilar and non-hilar obstruction. J Vasc Intervent Radiol 1993;4:597-604.
40. Cumhur T, Özmen MN, Akhan O, Ölçer T, Çekirge S, Özdemir E. Malignant biliary obstruction: treatment with self-expandable metallic stents. Eur Radiol 1995;5:6-12.
41. Gordon RL, Ring EJ, LaBerge JM, Doherty MM. Malignant biliary obstruction: treatment with expandable metallic stents. Follow-up of 50 consecutive patients. Radiology 1992; 182:697-701.
42. Bonnel D, Liguory C, Lefebvre JF, Cornud F. Traitement percutané des sténoses malignes du hile. Gastroenterol Clin Biol 1995; 19:564-71.
43. Nicholson AA, Royston CMS. Palliation of inoperable biliary obstruction with self-expanding metal endoprostheses: a review of 77 patients. Clin Radiol 1993;47:245-50.
44. Valette PJ. Traitement des sténoses tumorales du hile hépatique. Gastroenterol Clin Biol 1995;19:561-3.
45. Buffet C, Couderc T, Fritsch J, Choury A, Lefebvre JF, Marteau V, et al. Traitement palliatif par endoprothèse des ictères par obstacle tumoral biliaire sous-hilaire. Gastroenterol Clin Biol 1993; 17:629-35.
46. Speer AG, Cotton PB, Russell RCG, Mason RR, Hatfield ARW, Leung JWC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987;2:57-62.
47. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstuction. Lancet 1992;340:1488-92.
48. Ducreux M, Liguory C, Lefebvre JF, Ink O, Choury A. Fritsch J, et al. Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 1992;37:778-83.
49. d'Alincourt A, Hamy A, Thibaud C, Redon H, Paineau J, Lerat F. Ictères obstructifs néoplasiques: apport des prothèses métalliques percutanées. Gastroenterol Clin Biol 2000;24:770-5.
50. Kubota Y, Nakatani S, Nakahashi Y, Takaoka M, Kin H, Inoue K. Bilateral internal biliary drainage of hilar cholangiocarcinoma with modified Gianturco Z stents inserted via a single percutaneous tract. J Vasc Intervent Radiol 1993;4:605-10.
51. Lee MJ, Dawson SL, Mueller PR, Saini S, Hahn PF, Goldberg MA, et al. Percutaneous management of hilar biliary malignancies with metallic endoprostheses: results, technical problems, and causes of failure. Radiographics 1993;13:1249-63.
52. Rieber A, Brambs HJ. Metallic stents in malignant biliary obstruction. Cardiovasc Intervent Radiol 1997;20:43-9.
53. Carr-Locke DL, Bull TJ, Counors PJ, Cotton PB, Geenen JE, Hawes RH, et al. Multicentered, randomised trial of Wallstent biliary endoprothesis versus plastic stents. Gastrointest Endosc 1993;39:310.
54. Knyrim K, Wagner JH, Pausch J, Vakil N. A prospective randomised, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993;25:207-12.
55. Prat F, Chapat O, Ducot B, Ponchon T, Pelletier G, Fritsch J, et al. Randomised trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998;47:1-7.
56. Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant striture treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988;34;95-101.
57. Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989 Aug;30(8): 1132-5.
58. Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988 Dec;75(12): 1166-8.
59. Taylor MC, McLeod RS, Langer B. Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis. Liver Transpl 2000 May;6(3): 302-8.
60. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994 Dec 17;344(8938): 1655-60.
61. Polydorou AA, Cairns SR, Dowsett JF, Hatfield ARW, Salmon PR, Cotton PB, et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991;32:685-89.
62. Glimelius B, Hoffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996; 7:593-600.
63. Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resecable cholangiocarcinoma. Gut 1996;39: 852-5.
64. Ducreux M, Rougier P, Fandi A, Clavero-Fabri MC, Villing AL, Fassone F, et al. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 1998;9:653-6.
65. Taïeb J, Mitry E, Boige V, Artru P, Eznfis J, Lecomte T, et al. Optimization of 5 fluorouracil (5FU) cisplatin combination chemotherapy with a new schedule of leucovorin, 5 FU cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Ann Oncol 2002;13: 1192-6.